Switching From Daily DPP-4 Inhibitor to Once-Weekly GLP-1 Receptor Activator Dulaglutide Significantly Ameliorates Glycemic Control in Subjects With Poorly Controlled Type 2 Diabetes Mellitus: A Retrospective Observational Study.

Front Endocrinol (Lausanne) · 2021 · PMC8415741 · PMID 34484124

Europe PMC DOI

hedged sentence

0.0609

closest p · 1.2× alpha

0.0609

boldest claim

The sentences

did not reach statistical significancep = 0.0609so close (0.05 < p ≤ 0.1)

There was a trend between ΔBMI and ΔHbA1c even though it did not reach statistical significance ( ρ = 0.3154, p = 0.0609).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.